New biomarker combo could slash unnecessary antibiotics in sick newborns
NCT ID NCT03299751
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 30 times
Summary
This study looked for better ways to diagnose late-onset sepsis in newborns at least 7 days old in the NICU. Researchers tested combinations of blood markers to see which could accurately rule out infection early. The goal is to reduce unnecessary antibiotic use, which can cause resistance and other complications. The study included 233 babies with signs of infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LATE-ONSET NEONATAL SEPSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Nantes
Nantes, France
-
Hospices Civils de Lyon
Bron, 69500, France
Conditions
Explore the condition pages connected to this study.